Agios Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 5.59 M | $152.28 M | -0.19% | 9.65% |
| BLACKROCK, INC. | 02/12/2026 | 5.24 M | $142.51 M | 15.17% | 9.03% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/17/2026 | 5.16 M | $140.44 M | -10.75% | 8.90% |
| STATE STREET CORP | 02/13/2026 | 3.11 M | $84.60 M | 37.36% | 5.36% |
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 3.04 M | $82.64 M | 297.38% | 5.24% |
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 3.00 M | $81.66 M | 233.33% | 5.17% |
| ERSTE ASSET MANAGEMENT GMBH | 02/11/2026 | 2.80 M | $76.34 M | 1.45% | 4.82% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.84 M | $50.01 M | 399.58% | 3.17% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 02/17/2026 | 1.70 M | $46.31 M | 100.00% | 2.92% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.41 M | $38.48 M | -0.20% | 2.44% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/13/2026 | 1.36 M | $37.04 M | 37.82% | 2.35% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.35 M | $36.72 M | 174.19% | 2.33% |
| BIOIMPACT CAPITAL LLC | 02/17/2026 | 1.30 M | $35.48 M | 100.00% | 2.25% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/13/2026 | 1.28 M | $34.83 M | 0.00% | 2.21% |
| GW&K INVESTMENT MANAGEMENT, LLC | 02/11/2026 | 1.21 M | $32.86 M | 41.55% | 2.08% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/17/2026 | 1.18 M | $32.17 M | -17.36% | 2.04% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 1.14 M | $31.10 M | 100.00% | 1.97% |
| JANE STREET GROUP, LLC | 02/12/2026 | 1.12 M | $30.51 M | 183.72% | 1.93% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.03 M | $28.14 M | 28.48% | 1.78% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 1.00 M | $27.34 M | -1.65% | 1.73% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 903.90 K | $24.60 M | 439.32% | 1.56% |
| MORGAN STANLEY | 02/13/2026 | 894.04 K | $24.34 M | 114.40% | 1.54% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 836.00 K | $22.76 M | 212.76% | 1.44% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 799.16 K | $21.75 M | -16.63% | 1.38% |
| CAPITAL INTERNATIONAL INVESTORS | 02/11/2026 | 703.87 K | $19.16 M | 100.00% | 1.21% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 637.89 K | $17.36 M | -61.50% | 1.10% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 635.07 K | $17.29 M | 28.17% | 1.10% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 597.83 K | $16.27 M | -75.81% | 1.03% |
| SCS CAPITAL MANAGEMENT LLC | 02/10/2026 | 598.77 K | $16.30 M | 0.00% | 1.03% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 562.64 K | $15.32 M | 6.14% | 0.97% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 539.34 K | $14.68 M | -52.27% | 0.93% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 02/17/2026 | 530.00 K | $14.43 M | 100.00% | 0.91% |
| NORTHERN TRUST CORP | 02/17/2026 | 511.90 K | $13.93 M | -7.83% | 0.88% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 02/17/2026 | 504.49 K | $13.73 M | 25.20% | 0.87% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 482.62 K | $13.14 M | 0.09% | 0.83% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/17/2026 | 466.15 K | $12.69 M | -31.44% | 0.80% |
| ALGERT GLOBAL LLC | 02/17/2026 | 414.22 K | $11.28 M | 1,058.00% | 0.71% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 398.27 K | $10.84 M | 7,788.04% | 0.69% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 378.37 K | $10.30 M | 100.00% | 0.65% |
| MARSHALL WACE, LLP | 02/13/2026 | 353.64 K | $9.63 M | 55.91% | 0.61% |
| LEGAL & GENERAL GROUP PLC | 02/09/2026 | 328.21 K | $8.93 M | 1.63% | 0.56% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 325.00 K | $8.85 M | 155.91% | 0.56% |
| BARCLAYS PLC | 02/13/2026 | 320.35 K | $8.72 M | 48.28% | 0.55% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 300.16 K | $8.17 M | 403.37% | 0.52% |
| NUVEEN, LLC | 02/12/2026 | 297.91 K | $8.11 M | 149.13% | 0.51% |
| JPMORGAN CHASE & CO | 02/11/2026 | 251.78 K | $6.85 M | 37.51% | 0.43% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 242.67 K | $6.61 M | 1,551.04% | 0.42% |
| TREXQUANT INVESTMENT LP | 02/17/2026 | 226.60 K | $6.17 M | 100.00% | 0.39% |
| PALO ALTO INVESTORS LP | 02/17/2026 | 212.50 K | $5.78 M | -19.96% | 0.37% |
| CITADEL ADVISORS LLC | 02/17/2026 | 209.70 K | $5.71 M | 441.86% | 0.36% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Agios Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 362 institutional investors and hedge funds held shares of Agios Pharmaceuticals Inc. The most heavily invested institutionals were:
Erste Asset Management GmbH: 2.7 M
Lynx1 Capital Management LP: 2.61 M
DIMENSIONAL FUND ADVISORS LP: 1.15 M
Nuveen, LLC: 722,348
JANE STREET GROUP, LLC: 685,240
SCS Capital Management LLC: 612,850
105.37% of Agios Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 86.50 M shares in the last 24 months. This purchase volume represents approximately $2.47 B in transactions.